Kalpataru Projects International Limited announced the appointment of Mr. Amit Uplenchwar as Joint Managing Director & CEO, effective January 1, 2027, for a five-year term. The Board also approved his appointment as an Additional Director. Additionally, the company approved the reclassification request of Mr. Imtiaz Kanga and Mrs. Yasmin Imtiaz Kanga from ‘Promoter Group’ to ‘Public’ category, subject to shareholder approval.
Leadership Transition at Kalpataru Projects International
The Board of Directors of Kalpataru Projects International Limited (KPIL) has approved the elevation of Mr. Amit Uplenchwar (DIN: 06862760) to the position of Joint Managing Director & CEO (designate). This decision, made upon the recommendation of the Nomination and Remuneration Committee, signifies a key leadership change for the company.
Appointment Details and Term
Effective from January 1, 2027, Mr. Uplenchwar will also serve as an Additional Director, Joint Managing Director & CEO (Key Managerial Personnel). His tenure is set for a period of five years, commencing on January 1, 2027, and concluding on December 31, 2031. This appointment is subject to the requisite approval from the company’s shareholders.
The company confirmed that Mr. Uplenchwar has no familial relationship with any existing Director on the Board and is not debarred from holding a directorship by any regulatory authority. A detailed profile of Mr. Uplenchwar has been provided as ‘Annexure A’.
Reclassification of Promoter Group Members
In a separate resolution, the Board considered and approved the reclassification requests received from Mr. Imtiaz Kanga and Mrs. Yasmin Imtiaz Kanga. They have sought to be reclassified from the ‘Promoter Group’ category to the ‘Public’ category, in accordance with Regulation 31A of the applicable regulations. The Board found that the conditions prescribed under Regulation 31A(3)(b) were met, and accordingly, approved the reclassification. This is contingent upon obtaining necessary approvals, including shareholder consent and the completion of the prescribed regulatory process.
Source: BSE
